UPDATE: Morgan Stanley Upgrades Carvana (CVNA) to Overweight, Sees >60% Upside

Carvana (CVNA) PT Lowered to $285 at BofA Securities

BofA Securities analyst Nat Schindler lowered the price target on Carvana (NYSE: CVNA) to $285.00 (from $320.00) while maintaining a Neutral rating.

Carvana (CVNA) PT Raised to $250 at Stephens

Stephens analyst Rick Nelson raised the price target on Carvana (NYSE: CVNA) to $250.00 (from $225.00) while maintaining a Equal Weight rating.... More

Carvana (CVNA) PT Raised to $290 at JMP Securities

JMP Securities analyst Ronald Josey raised the price target on Carvana (NYSE: CVNA) to $290.00 (from $250.00) while maintaining a Market Outperform rating.... More

After-Hours Stock Movers 02/25: (SEM) (GPRN) (SFM) Higher; (TCDA) (SPCE) (DASH) Lower (more...)

Today's After-Hours Movers:

Tricida, Inc. (Nasdaq: TCDA) 23.3% LOWER; received an Appeal Denied Letter (ADL), from the Office of New Drugs (OND) of the FDA in response to its Formal Dispute Resolution Request (FDRR) submitted in December 2020. While the FDRR was focused on whether the magnitude and durability of serum bicarbonate change seen in the TRCA-301/TRCA-301E trial is reasonably likely to predict clinical benefit in the treatment of metabolic acidosis in patients with CKD, the ONDs decision additionally addressed other deficiencies identified in the Complete Response Letter (CRL),... More

Carvana Co. (CVNA) Misses Q4 EPS by 40c, Revenue Beats

Carvana Co. (NYSE: CVNA) reported Q4 EPS of ($0.87), $0.40 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $1.83 billion versus the consensus estimate of $1.6 billion.

For earnings history and earnings-related data on Carvana Co. (CVNA) click here.